巨人網絡(002558.SZ):已上線產品有三款《原始征途》、《太空行動》及《龍與世界的盡頭》
格隆匯5月6日丨巨人網絡(002558.SZ)近日接受機構調研,問答環節中,就“公司產品儲備情況及推廣計劃?”,公司回覆稱,已上線產品有三款:(1)《原始征途》已於2023年3月上線,後續將持續版本更新、內容優化。(2)《太空行動》已於2023年1月上線,預計2023年暑期開啟大規模推廣活動。(3)《龍與世界的盡頭》於2023年3月在中國台港澳地區上線公測,表現達到預期。後續公司將繼續優化版本,提升中長留及商業化,有望於暑期開啟公測。
儲備產品有:(1)《王者征途》是“征途”IP的H5遊戲。(2)一款面向全球市場,以國戰為核心玩法,以西方魔幻為題材的3DMMORPG手遊。(3)一款面向全球市場的SLG產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.